Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors With MAPK Pathway Mutations

Explore clinical trials studying Advanced Solid Tumors With MAPK Pathway Mutations. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Advanced Solid Tumors With MAPK Pathway Mutations trial results

Recruiting

A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

NCT05886920

Conditions
Advanced Solid Tumors With MAPK Pathway Mutations
Locations
  • D3 Bio Investigative Site Detroit, Michigan, United States
  • D3 Bio Investigative Site New York, United States
  • D3 Bio Investigative Site Nashville, Tennessee, United States
  • D3 Bio Investigative Site Blacktown, New South Wales, Australia
View all 14 locations
View Trial Details